This assay has been shown to recapitulate the correct expression pattern for the SBE2 enhancer and to detect the loss of this enhancer activity associated with mutation of a SIX3 binding site found in the cases of HPE [16,27]. Here, SIX3 is linked to holoprosencephaly.